Full text is available at the source.
Design, Synthesis, and Activity Evaluation of GK/PPARγ Dual‐Target‐Directed Ligands as Hypoglycemic Agents
Design and testing of compounds targeting GK and PPARγ to lower blood sugar
AI simplified
Abstract
Three compounds demonstrated high potency toward glucokinase and moderate activity toward PPARγ.
- A multi-target strategy was employed to develop agents for treating type 2 diabetes mellitus.
- Dual-target molecules were created by integrating features from known glucokinase activators and PPARγ agonists.
- The dual-target agents were assessed for their ability to activate transcription for both GK and PPARγ.
- Preliminary analysis of structure-activity relationships was conducted for the synthesized compounds.
- Molecular docking simulations were performed to explore the binding modes of one of the most effective compounds.
AI simplified